This webinar, hosted by Sano CEO Dr. Patrick Short and featuring David Ochoa, Platform Coordinator at Open Targets, explores the significance of human genetics ...
Continue reading
As precision medicine trials increasingly depend on genetic eligibility criteria, the process of testing, interpreting results, and guiding patients through the...
Continue reading
Genetic testing has become a defining capability in biotechnology and pharmaceutical development. By revealing the specific genetic variants that influence dise...
Continue reading
Digital twins are virtual models designed to accurately reflect a physical object or system. The concept comes from engineering and has been applied to complex ...
Continue reading
While lifestyle choices and environment can impact risk, genes are often what most affect how likely a person is to develop a disease. People commonly have diff...
Continue reading
For most clinical programs, recruitment is the single largest source of delay. It is often more operationally complex than the trial itself, and when it underpe...
Continue reading
CRISPR (clustered regularly interspaced short palindromic repeats) and CRISPR-associated (Cas) proteins were first characterized as part of bacterial immune def...
Continue reading
Metabolic dysfunction-associated steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis (NASH), is a progressive liver disease driven by fat a...
Continue reading
Pharmacogenomics, also known as pharmacogenetics, is a field of research dedicated to investigating how an individual's genetic makeup influences their response...
Continue reading
This webinar, hosted by Sano CEO Dr. Patrick Short and featuring Dr. Dimitar Tonev, an expert in liver disease and hepatology, sheds light on the latest develop...
Continue reading